CNY 13.31
(-0.15%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5.94 Billion | 1.95 Billion | -6.85 Billion | -5.37 Billion | 1.24 Billion | 919.72 Million |
Net Income | 671.31 Million | 965.43 Million | 1.17 Billion | 787.92 Million | 686.48 Million | 71.65 Million |
Depreciation & Amortization | 270.53 Million | 191.98 Million | 174.06 Million | 159.79 Million | 140.46 Million | 64.35 Million |
Deferred income taxes | 214.75 Million | 190.35 Million | 34.1 Million | -1.09 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 4.73 Billion | 1.29 Billion | -8 Billion | -6.27 Billion | 608.5 Million | 346.76 Million |
Other non-cash items | -4.14 Billion | -500.24 Million | -198.47 Million | -40.88 Million | -194.67 Million | 436.94 Million |
Investing Cash Flow | -7.56 Billion | -2.16 Billion | -6.32 Billion | -1.33 Billion | 55.55 Million | -216.82 Million |
Investments in PPE | -198.54 Million | -112.42 Million | -106.72 Million | -86.3 Million | -84.68 Million | -82.21 Million |
Acquisitions | -2.12 Billion | 47.4 Million | 4.25 Million | 1.92 Million | 15.96 Million | 817 Thousand |
Investment purchases | -18.26 Billion | -9.22 Billion | -9.81 Billion | -3.46 Billion | -6.23 Billion | -830.19 Million |
Sales/Maturities of investments | 13.02 Billion | 6.71 Billion | 3.33 Billion | 2.02 Billion | 6.33 Billion | 688.22 Million |
Other Investing Activities | -1.00 | 416.98 Million | 258.15 Million | 193.63 Million | 16.44 Million | 7.35 Million |
Financing Cash Flow | 3.72 Billion | 1.53 Billion | 9.17 Billion | 9.13 Billion | -609.28 Million | -490.23 Million |
Debt repayment | -4.6 Billion | -15.82 Billion | -10.34 Billion | -10.16 Billion | -2.78 Billion | -3.2 Billion |
Dividends payments | -763.42 Million | -283.17 Million | -285.37 Million | - | -95.12 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 4.98 Billion | 1.95 Billion | - | - |
Other Financing Activities | -763.42 Million | 17.64 Billion | 14.82 Billion | 17.34 Billion | 2.26 Billion | 2.7 Billion |
Accounts receivables | -1.4 Billion | -490.51 Million | -3.74 Billion | -3.9 Billion | - | - |
Accounts payables | 6.14 Billion | 5.81 Billion | 8.49 Billion | 8.01 Billion | - | - |
Inventory | -8.11 Billion | - | - | - | - | - |
Other working capital | 8.11 Billion | -4.02 Billion | -12.75 Billion | -10.38 Billion | 608.5 Million | 1 Billion |
Cash at beginning of period | 2.06 Billion | 2.39 Billion | 6.39 Billion | 3.96 Billion | 3.26 Billion | 3.04 Billion |
Cash at end of period | 3.16 Billion | 3.72 Billion | 2.39 Billion | 6.39 Billion | 3.96 Billion | 3.26 Billion |
Capital Expenditure | -198.54 Million | -112.42 Million | -106.72 Million | -86.3 Million | -84.68 Million | -82.21 Million |
Effect of forex changes on cash | 1.3 Million | 3.35 Million | -2.57 Million | 2.78 Million | 6.04 Million | 13.6 Million |
Net cash flow / Change in cash | 1.09 Billion | 1.32 Billion | -4 Billion | 2.43 Billion | 693.09 Million | 226.26 Million |
Free Cash Flow | 5.74 Billion | 1.84 Billion | -6.96 Billion | -5.45 Billion | 1.15 Billion | 837.5 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 308.14 Million | 306.46 Million | -218.75 Million | -55.46 Million | 671.31 Million | 126.46 Million |
Depreciation & Amortization | - | 76.39 Million | 76.39 Million | 75.92 Million | 270.53 Million | 6.64 Billion |
Deferred income taxes | - | - | - | - | 214.75 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 5.22 Billion | - | 8.11 Billion | 4.73 Billion | -2.28 Billion |
Other non-cash items | 7.59 Billion | 6.21 Billion | -800.13 Million | 7.23 Billion | -4.14 Billion | 8.9 Billion |
Investing Cash Flow | -652.1 Million | -168.29 Million | 2.64 Billion | -7.22 Billion | -7.56 Billion | 1.42 Billion |
Investments in PPE | -31.99 Million | -34.17 Million | -38.13 Million | -71.37 Million | -198.54 Million | -34.65 Million |
Acquisitions | 182.28 Thousand | -5.64 Million | 5.66 Million | -5.17 Million | -2.12 Billion | 12.98 Billion |
Investment purchases | -747.67 Million | -2.24 Billion | -745.71 Million | -9.99 Billion | -18.26 Billion | 1.41 Billion |
Sales/Maturities of investments | 127.38 Million | 2.11 Billion | 3.36 Billion | 2.84 Billion | 13.02 Billion | 1.47 Billion |
Other Investing Activities | - | -1.07 Billion | 2.68 Billion | -984.52 Million | -1.00 | -14.41 Billion |
Financing Cash Flow | -2.14 Billion | -246.5 Million | 1.17 Billion | -354.19 Million | 3.72 Billion | 12.41 Billion |
Debt repayment | -5.27 Billion | -6.78 Billion | -3.19 Billion | -19.44 Billion | -4.6 Billion | -11.03 Billion |
Dividends payments | - | - | -234.56 Million | - | -763.42 Million | -721.92 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -7.41 Billion | -199.03 Million | -36.86 Million | 42.08 Million | -763.42 Million | 24.16 Billion |
Accounts receivables | - | - | - | - | -1.4 Billion | - |
Accounts payables | - | - | - | - | 6.14 Billion | - |
Inventory | - | - | - | - | -8.11 Billion | - |
Other working capital | - | 5.22 Billion | - | 8.11 Billion | 8.11 Billion | -2.28 Billion |
Cash at beginning of period | 7.72 Billion | 5.65 Billion | 15.68 Billion | 4.41 Billion | 2.06 Billion | 8.76 Billion |
Cash at end of period | 6.11 Billion | 7.72 Billion | 18.49 Billion | 3.16 Billion | 3.16 Billion | 13.58 Billion |
Capital Expenditure | -31.99 Million | -34.17 Million | -38.13 Million | -71.37 Million | -198.54 Million | -34.65 Million |
Effect of forex changes on cash | - | 757.31 Thousand | 90.68 Thousand | -1.87 Million | 1.3 Million | 80.09 Million |
Net cash flow / Change in cash | -1.61 Billion | 2.06 Billion | 2.8 Billion | -1.25 Billion | 1.09 Billion | 4.81 Billion |
Free Cash Flow | 7.87 Billion | 6.41 Billion | -1.05 Billion | 7.03 Billion | 5.74 Billion | 13.35 Billion |
UNICK
EQH-PA
FIQE3
PK
MNESP
SEPL